Adagene (NASDAQ:ADAG) Rating Reiterated by HC Wainwright
Adagene (NASDAQ:ADAG – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at HC Wainwright in a research report issued to clients and investors on Monday, Benzinga reports. They currently have a $5.00 price target on the stock. HC Wainwright’s price target would indicate a potential upside of 92.31% from the company’s […]
More Stories
FY2025 EPS Estimates for Extendicare Increased by Analyst
Extendicare Inc. (TSE:EXE – Free Report) – Equities researchers at Leede Financial upped their FY2025 earnings per share estimates for...
FY2025 EPS Estimates for Extendicare Increased by Analyst
Extendicare Inc. (TSE:EXE – Free Report) – Equities researchers at Leede Financial upped their FY2025 earnings per share estimates for...
FY2025 EPS Estimates for Extendicare Increased by Analyst
Extendicare Inc. (TSE:EXE – Free Report) – Equities researchers at Leede Financial upped their FY2025 earnings per share estimates for...
FY2026 EPS Estimates for Precigen Decreased by HC Wainwright
Precigen, Inc. (NASDAQ:PGEN – Free Report) – Research analysts at HC Wainwright reduced their FY2026 earnings per share estimates for...
FY2026 EPS Estimates for Precigen Decreased by HC Wainwright
Precigen, Inc. (NASDAQ:PGEN – Free Report) – Research analysts at HC Wainwright reduced their FY2026 earnings per share estimates for...
FY2026 EPS Estimates for Precigen Decreased by HC Wainwright
Precigen, Inc. (NASDAQ:PGEN – Free Report) – Research analysts at HC Wainwright reduced their FY2026 earnings per share estimates for...